Werner Cautreels

Werner Cautreels is currently Chairman-Supervisory Board at Cristal Delivery BV since 2019.
Dr. Cautreels is Director at Third Pole, Inc. since 2021.
Dr. Cautreels is Director at Thrombolytic Science International LLC.
Dr. Cautreels is Director at Traws Pharma, Inc. starting 2025.
Formerly, Dr. Cautreels was Global Chief Executive Officer at Solvay Pharmaceuticals SA from 2005 to 2010.
Dr. Cautreels was Non-Executive Chairman at MRM Health NV from 2020 to 2026.
Dr. Cautreels was Director at ArQule, Inc. from 1999 to 2006.
Dr. Cautreels was Independent Non-Executive Director at Lakefront Biotherapeutics.
Dr. Cautreels was Director at Selecta Biosciences, Inc. in 2018.
Dr. Cautreels was Director at Fujirebio Europe NV from 1999 to 2006.
Dr. Cautreels was Independent Director at Seres Therapeutics, Inc. from 2013 to 2016.
Dr. Cautreels was General Manager-Pharmaceuticals at Solvay SA in 2010.
Dr. Cautreels was Senior Vice President-Research & Development at Nycomed Amersham Medical Systems from 1994 to 1998.
Dr. Cautreels was Principal at Sterling Winthrop, Inc. from 1979 to 1994.
Dr. Cautreels was Vice President-Scientific Affairs at Sanofi-Aventis U.S.
LLC from 1979 to 1994.
Dr. Cautreels was President at Belgian Luxembourg Chamber of Commerce for Russia & Belarus in 2010.
Education includes undergraduate, graduate, and doctorate degrees from the University of Antwerp and an MBA from Harvard Business School.